AN2 Therapeutics, Inc. Reports Inducement Grants Under Listing Rule 5635(c)(4)
AN2 Therapeutics granted inducement equity awards to two newly hired employees under Nasdaq Listing Rule 5635(c)(4). The October 19 grants consist of options to purchase 10,565 shares at $3.37 per share plus 5,283 RSUs, with standard four-year vesting.
Key figures
- Exercise price
- 3.37
- Inducement rsus
- 5283
- Inducement options
- 10565
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.